{"name":"Syndax Pharmaceuticals","slug":"syndax-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNckJhQ3oxRUo2T05ycTF2cGoxM2ZOcy0tRTJIVU9jNTlxSU94Y1l2ODlTVVNYYWJBWEVxQ1lWa3ZCNG1NRVZwQ3V0U3pTbHcwNlNYQnhhV1RjNk41UHdEWU9zN1FjSUFKY080S0J4bVIwUlU1cV85UVVGNkJqVkZWVXNaU0xReC00bnFrdElwNTNQREM5ZkRzSlZiQVFPenphbHpz?oc=5","date":"2026-03-18","type":"pipeline","source":"Seeking Alpha","summary":"Syndax Pharma: Two Drug Launches Fuel Transformational Growth (NASDAQ:SNDX) - Seeking Alpha","headline":"Syndax Pharma: Two Drug Launches Fuel Transformational Growth (NASDAQ:SNDX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQZVBXSjZ2Tzc1NEhHSDF0RFBQaVE0M3ZHeGV1a09MdnFES0NMTjBEdm1GVkRQMjQ3aXRYNW1SVnhaRVhnY01WYTcwSk9GTmxmR3psMHNUVTBTWVBmcC0tcG9yakl2RjRrbDdtS0pibU14U0JQY0hGSnpyWUtjSXhHdS05UVZsd2hfVlk1cDUtWHVweFoyVUZZN3h6R1V1c2U5VWRFalJQc25kNG01eGc?oc=5","date":"2026-02-10","type":"pipeline","source":"Investing.com","summary":"Syndax Pharma CFO Goldan sells $71k in shares - Investing.com","headline":"Syndax Pharma CFO Goldan sells $71k in shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNOTBZMjJnaDNZOUZDSWxfYnpHaFZFUFVDWXd3Qnc5dmN2c0dDOHpQd3VKTVVfemxTWlZkVlFoYUpEV3Y3WGxsVFJZSkNZajlMQmhPWThfTTJTTmtjaWIzLTVGMGtpWUdqdkVlTjVuOGlpNDJ1UlF5dmtlRWZ4dF9VR3RYbm5SZDltY3dETE9YcHN2eWpBajRVTlNfSXVuRkFFcy1mXzJJOFpKTEY1OWE0eg?oc=5","date":"2026-02-06","type":"pipeline","source":"Investing.com","summary":"Syndax Pharma CFO Goldan sells $42930 in shares - Investing.com","headline":"Syndax Pharma CFO Goldan sells $42930 in shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOQXhmMmlXZVpnaXhuUno2ZWpTMVVVU2JnSS1YeGNqTnktN1RMM0JoVmNDTDJ4U0djcmlrOUhlQzI5dkJOTWFLMkRRSUExc1c3dkJJY3RkaTY0Tm0xU2J3ekh3XzFBMmRUWHl6UHM5bWFPZmJkNS1xbXFrZkxEZUU4V3l0Ylo1cUc4dHJhdVYwbFVLZw?oc=5","date":"2025-12-17","type":"pipeline","source":"Seeking Alpha","summary":"Syndax Pharma: Continuing Execution In AML (NASDAQ:SNDX) - Seeking Alpha","headline":"Syndax Pharma: Continuing Execution In AML (NASDAQ:SNDX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOZ1AtRnRGeXB4WmpmVFZwcHZ6czc2UjlmVW05TFEzRU9FTnNia0V4QmpLWWpvT2JiTV9BNmIyelBjQzVGTUtaMDl6ZFZzOERwYlBjanZERVFmWUlMTU52MGRBU0lzcUdzUVpCNWxFNnpyRElwRUtCLTE3YXNtRDZLR3RVMVZCNlNqYTlnMFJBbEM?oc=5","date":"2025-12-06","type":"regulatory","source":"statnews.com","summary":"‘Remarkable’ drug results against an aggressive leukemia - statnews.com","headline":"‘Remarkable’ drug results against an aggressive leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNZFVLZTAyYWp4SkhHdUJ6V05zRk1LZi1IcEllNGpGQ1NvVjBWS1lCaHh0aFFWdXpyUlVwaU4yMW9zMHhKZHFfQ29KLWJQcVpmS1BXeFItTlRrVVYyakxUb2diNHhOV1hOVDZuV00zNE40QjdpWDFFV21fOWdJbVNLak5sc0lkQQ?oc=5","date":"2025-11-14","type":"regulatory","source":"pharmaphorum","summary":"Kura scores FDA okay for rival to Syndax's leukaemia drug - pharmaphorum","headline":"Kura scores FDA okay for rival to Syndax's leukaemia drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQaFZkVWRyaDE5cDhzbFVQT0NmbjBiZWo1WkpjeEZMUzhKaWMyMlpDRGRJZXB2SW95YzdWeXlfbjNrTnFvd25wcEx3RVRrdzFMbkF0cnNGUkdIZjFqRTdvZEVYSW1ZYV9MVUlLVVBtSmM3VHp0M0U1Q3RkUHI4WXBNRmpzcjJtb0pYUzBaNVMtVE5RMXB0T0NwbXEySWwwdw?oc=5","date":"2025-11-13","type":"regulatory","source":"MedCity News","summary":"FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma - MedCity News","headline":"FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNWjRqdTdlWmhYUHBnWXg2VjhZQVV1aTdBdm9FaVlqUEVyR05BSHFpcXJkQTZNMHF2T1RRcHd6cGRoa2JwemoxWWJFRHlMczR2aWJDRmZ6cE1YVktFRFJISzI2YXluWGtRS3hreU1NbnEwSzJoYjBBRERyMTlwdGpPTTZDajdiUnBtbEp3TkdYY291aWhQbU56cS1EM3FJT01Xb3FOZE42dUo3aHlwb1p4YjVTcXg3UVZCYzlfU1ZUWWpFQQ?oc=5","date":"2025-11-13","type":"regulatory","source":"Fierce Pharma","summary":"Kyowa's bet on Kura pays off as partners' oral med for AML subset wins FDA approval - Fierce Pharma","headline":"Kyowa's bet on Kura pays off as partners' oral med for AML subset wins FDA approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNSkdyWW1DZjJkU1NaNkVyNjVfQmZOWHVwUmJsYWpvY1lGY25tNkZ3YzFWc09oYUMxYWNHSDl2eTRkZHpJNGdEWGdsc0FBNThGdlphc2Y5SE9xaGNMN2lQLUlNRHFKSTBhLU1UamNFaWVjeFVOSGxkX2pSb0I5X3BaX3NBQzdYdmVrRmdSck5uWFB6ekNWRnlfRW44bnFvbVJhZDhVcGJrUkZHeDBNZmJNSFkzRTFjUmR2WnFBZjNn?oc=5","date":"2025-11-05","type":"pipeline","source":"Seeking Alpha","summary":"Syndax Pharmaceuticals: Thesis Firing On All Cylinders, Sales Acceleration In 2026 (SNDX) - Seeking Alpha","headline":"Syndax Pharmaceuticals: Thesis Firing On All Cylinders, Sales Acceleration In 2026 (SNDX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQS1R4QXhkejJ0RldrMkhzai11VW9UbTFncjNGYmRHVkZTNGdtVENmVDRlUkFaQkFJMTZGWklQRFdLdzBtbUpxMEFJWmR5Y3VJMnhEZlgtamZwVUhXSEFFWUU0aUt4NWVkUXBkdGJCNmlrZ2gtdGhlY0d0Z2VsTVo1QWxIOXlOVG1pVHVHTg?oc=5","date":"2025-10-27","type":"regulatory","source":"statnews.com","summary":"Syndax leukemia drug wins FDA expanded approval - statnews.com","headline":"Syndax leukemia drug wins FDA expanded approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQYXFKSlhvNzdfRUZRdW5pMGFaYVVGU281eHRiY29NRmJNRS1seTNKZ3I5dWQ0NElkdHdMQzlwdzBUUVdKY1ZkNFpmNVlyLUtuLW9hR0RIQ2JrcXpIamRneEFDRDlYcTFRd1A0cWN2X2dvSmFlNEg5aXVDcE5iWTZIcFhxRGhIbUU0UndR?oc=5","date":"2025-10-27","type":"regulatory","source":"The Pharma Letter","summary":"New FDA green light for Syndax’ Revuforj - The Pharma Letter","headline":"New FDA green light for Syndax’ Revuforj","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNOHhZTmFyblpuM3c1OFVTYzA1R28tdHNidE1XWHo5aWRuM3FtZC1zQlNCZlYzdnJGRFptSmRwdTVBYVk0U2dGeXFwTG5vRGhNci1QOXJLMzhpcmhLY3JPd1NGdEZWWW1hakZtSFc3YjBSVDdRWml2WU1ZNnZRcFg3VlBHdjR1SXNDcE5fdQ?oc=5","date":"2025-05-16","type":"pipeline","source":"Fierce Biotech","summary":"BMS oncology head swings to Syndax—Chutes & Ladders - Fierce Biotech","headline":"BMS oncology head swings to Syndax—Chutes & Ladders","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}